It's so peculiar when naysayers say things such as, "This

New Post Public Reply Private Reply Replies (1) Message Board
joey68
It's so peculiar when naysayers say things such as, "This thing is going to crash.."

Crash?

You mean drop in price? Is anyone here expecting 'this thing' to only go up without ever having a red day? I love red days when they are required to make a chart healthier!

Ive been saying all along the PPS may go back down to .001 (or lower for all we know), but based on DD, the price should technically go back up. This is why we're waiting on the 10K. Actually, this is the point of a 10K. For information.

Now, I could turn it around and ask the naysayer, "So, show me DD that says this company is failing.

Show me an article within the past year clearly stating the technology behind the WavSTAT4 does not work.

Sure, you could scrounge up some old trials which state the technology needs further testing, but what device doesn't need further testing? Heck, I want all the testing this thing can get!

Show me any article which says PENTAX is not working with SCIE.

Show me any article which says the WavSTAT4 is not being tested in the UK.

Show me ANYTHING stating Spectrascience does not have a distribution agreement with JAGWorldwide.

Show me any article stating some of the top leaders in the field have not reviewed and tested the WavSTAT4.

Disprove the WavSTAT4 mentioned on Aetna’s webpage.

Disprove the WavSTAT4 mentioned by Blue Cross/Blue Shield.

Disprove the WavSTAT4 was at the Arab Conference just a few short months ago.

Disprove the advancement of technology in general. Prove to us that standard colonoscopies will still be here in 3, 5, 10, and 50 years. That makes me laugh. Its like saying flat screen televisions should never have replaced the old tube TV.

Disprove there are current studies being performed with the WavSTAT4 in the Czech republic, Denmark, Germany, Italy, and Sweden.

Disprove that hospitals in France and other countries are collaborators for current WavSTAT4 trials.

Disprove the current need for better technology to save lives.

Disprove 14 million Americans alone get colonoscopies every year and that the current methods aren’t as efficient as the could be.

Disprove PENTAX has a 5 year distribution agreement with Spectrascience.

Disprove the WavSTAT4 is readily available for viewing on PENTAX’s websites for Italy, Spain, Germany, France, and the United Kingdom.

We're waiting......................................

Note
Any response which does not contain active links to disprove each and every one of the above statements, will be disregarded.

Note2
The funny thing is, all of the statements above don't even include all of the DD. That's how much information there is on Spectrascience.


SpectraSCIENCE Inc. (SCIE) Stock Research Links

SCIE Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 47

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
Danaher and Microsoft Put AI Into the Lab Stack Early

Updated Category News Views 103

Laboratory AI gets interesting only when it reaches the hardware bench, and Danaher is taking a serious swing at that ugly, complicated job with Microsoft. The Nov. 20 partnership is not just another chatbot bolted onto a dashboard. It is aimed at building a common agentic platform that can help instruments interpret scientific intent, guide setup, control hardware within...

Continue Reading
CCTV-4 Revisits China's Enduring Academy Tradition

Updated Category News Views 86

Stone courtyards, old books and hard questions are getting prime time on CCTV-4, which is a more interesting programming bet than it may first appear. Enduring Chinese Academies, a ten-episode cultural exploration series from China Media Group's Global Chinese Programming Center, is built around a simple theme: “One academy, one spirit.” It begins airing November 22...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 65

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Oatly’s $4.13 Tender Offer Is a Legal Detour, Not a Sale

Updated Category News Views 39

A $4.13 cash offer trading against a $7.17 close is the sort of thing that makes investors squint hard, and Verlinvest is practically waving a flag telling them why. This is not a conventional attempt to buy Oatly Group AB. It is a technical tender offer built to satisfy Swedish takeover rules while Verlinvest buys out its joint-venture partner’s interest in Oatly’s...

Continue Reading
Surgery Partners Deal Faces Fresh Price Scrutiny Ahead

Updated Category News Views 66

A $23.50 cash offer can look wonderfully tidy until somebody asks how the number was built. That is where Surgery Partners shareholders find themselves after Halper Sadeh LLC said it is investigating the proposed sale of Surgery Partners, Inc. to HealthSpan Partners. The firm is examining whether the company’s board obtained a fair price, ran a conflict-free process,...

Continue Reading
CITGO Sign Return Caps Kenmore's Careful Rebuild Work

Updated Category News Views 62

Thirty feet upward and 120 feet eastward is not the sort of move that usually stops a city in its tracks, yet Boston’s CITGO Sign was never merely rooftop hardware. Its public relighting in Kenmore Square marks the final phase of the redevelopment at 660 Beacon Street, and the real accomplishment is less flashy than the lights: a beloved, federally landmarked object...

Continue Reading
Sports Leagues Confront Youth Gambling's Hard Truth

Updated Category News Views 35

A stadium-sized advertising machine cannot pretend kids are not watching. That is the uncomfortable backdrop to the National Council on Problem Gambling's November 10 youth gambling prevention summit, where representatives from the NFL, MLB, NBA and PGA Tour met at the NFL's New York offices. Good that they showed up. Frankly, with gambling stitched into so much sports...

Continue Reading
University of Phoenix Poll Gets a Useful Reality Check

Updated Category News Views 0

Good Numbers, With the Usual Fine Print Employer approval is the kind of evidence career-focused schools desperately need, and University of Phoenix just put up a pretty loud batch of it. Among managers who directly supervise its graduates, 94% said the university understands employer needs, while 92% said its programs align with workforce demands. Those are stout...

Continue Reading
PexarBolt's CES Honor Meets a Real Crowdfunding Test

Updated Category News Views 32

A little touchscreen bolted onto a dock would usually make me roll my eyes. This time, Pexar has at least put enough muscle behind the gimmick to deserve a harder look. The PexarBolt Ultra TBT5 Dock was named a CES Innovation Awards 2027 Honoree in Computer Peripherals & Accessories, following an IFA 2026 Innovation Awards honor only two months after its launch. Awards do...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating the Shifting Landscape of European Credit Markets

Updated Category News Views 140

Understanding European Credit Markets In recent discussions, many have highlighted the significant progress in European equities, which have surged to unprecedented highs due to several bullish factors. These include attractive valuations, supportive monetary policies, evolving geopolitical conditions, and vital reforms. Similar Trends in Credit Markets However, it's...

Continue Reading
Exploring the Daily Fund Prices of WisdomTree ETFs

Updated Category News Views 153

Understanding Net Asset Values in WisdomTree ETFs When you dive into investments, net asset value (NAV) becomes a crucial concept, particularly within exchange-traded funds (ETFs). WisdomTree, recognized for its wide variety of ETFs, shares daily updates on its fund prices. This information is vital for investors who want to make informed choices. These daily fund prices...

Continue Reading
Ryan Mueller of MLG Capital Honored as Multifamily Influencer

Updated Category News Views 270

Ryan Mueller Recognized as a Multifamily Influencer MLG Capital, a prominent name in private real estate investments, has announced that Ryan Mueller, the Principal and Senior Vice President, has earned recognition as a 2025 Influencer in Multifamily Real Estate by GlobeSt. This prestigious accolade highlights Ryan's exceptional contributions and leadership in the sphere...

Continue Reading
Ames Watson Steps In to Lead Champion Brand's New Era

Updated Category News Views 491

Ames Watson Takes Charge of Champion's Collegiate and Teamwear Divisions Ames Watson is set to drive significant growth and innovation for the renowned sportswear brand Champion. Following a recent acquisition by Authentic Brands Group, Ames Watson will steer Champion's storied collegiate apparel and teamwear operations. This partnership marks a strategic step in...

Continue Reading
TFA Logistics Expands Operations with Dillon Transportation Deal

Updated Category News Views 586

TFA Logistics Expands Operations with Dillon Transportation Deal TFA Logistics, a prominent freight and logistics solutions provider, has successfully completed the acquisition of the assets belonging to Dillon Transportation. This strategic move significantly enhances TFA's national operations and adds over 130 talented employees to its team. Strengthening the National...

Continue Reading